Priests for Life told the D.C. Circuit Court of Appeals that the Obama administration’s latest efforts to accommodate religious objections to the birth control benefit fell short.
Pennsylvania officials will look into $48 million in undisclosed spending in the roll out of Healthy PA, the state’s alternative to Medicaid expansion.
Republicans are never going to successfully repeal health-care reform, so instead they hope to use the courts to gut the most popular and important provisions and render the law a political liability for Democrats.
The entity formerly known as Planned Parenthood of Hidalgo County is making a major branding switch: from now on, the provider will be known as Access Esperanza Clinics.
“You put me in charge of Medicaid, the first thing I’d do is get Norplant, birth-control implants, or tubal ligations. … Then we’ll test recipients for drugs and alcohol, and if you want to (reproduce) or use drugs or alcohol, then get a job,” Russell Pearce, the vice president of Arizona’s Republican Party, said on Sunday.
Suing to keep grown daughters from accessing contraception, or to keep employees from having coverage for contraception from somewhere besides the health-care plan you offer? Conservatives are getting aggressive in arguing they have a right to directly interfere with your ability to get contraception, and they may win.
Too often, reaching out for help can mean being handed off to people who have absolutely no training in mental health care and who have deep prejudices against those with mental illnesses.
Federal judges asked tough questions Friday morning during a lengthier-than-expected appeals court hearing concerning the enforcement of Texas’ omnibus anti-abortion law, HB 2.
When elected officials push policies to deny insurance coverage for abortion care, they make it unaffordable for many women to receive quality treatment. As a physician and as a woman, this concerns me immensely.
For women in countries and communities with limited contraceptive choices and high rates of HIV, particularly in sub-Saharan Africa, a shortage of funding for the ECHO (Evidence for Contraceptive Options and HIV Outcomes) trial is an unacceptable development.